NCT05027490

Brief Summary

Although it has been established that the perception of food and eating and cooking habits change during cancer and its treatment, quality of life related to meals, which is an indicator of the psychobiological and physiological well-being of patients in their relationship to food, has been little studied in the pathological context, and particularly in patients undergoing chemotherapy. Beyond its biological role, food plays a significant psychobiological and social role, as shown by a series of qualitative studies based on interviews with patients. Following a cancer diagnosis, loss of appetite, difficulty in sharing a meal with the family, and reduced pleasure in eating disrupt the patient's relationship with his or her food. Thus, side effects such as fatigue, nausea and vomiting, and alterations in taste and smell induced by chemotherapy will affect patients' eating behavior, increasing the risk of deteriorating their quality of life with food. As these side effects are less known and therefore less expected by patients, they often lack the information and tools necessary to understand them. The present study proposes a support for cancer patients treated by chemotherapy in order to improve their quality of life related to meals, and thus keep the pleasure of eating and reduce the risks of malnutrition. This support will consist of a guide provided to patients, in which they will have information on the functioning of the sensory systems involved in the eating experience, advice and culinary tips to adapt foods to their sensory disorders, and recipes that can be adapted in mild (for patients with hypersensitivity to tastes/smells), accentuated (for patients with hypersensitivity to tastes/smells) and enriched (for patients at risk of denutrition) versions. In addition, their sensory abilities will be assessed at the beginning of the study by psychophysical tests, then between each chemotherapy via a telephone interview (self-reported sensory abilities), and they will benefit from orientation according to the test results. This work will be a first action to improve the quality of life related to the meal by information, follow-up, and adaptation of the meals to the sensory performances of each patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
209

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 30, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

January 27, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2023

Completed
Last Updated

October 11, 2023

Status Verified

October 1, 2023

Enrollment Period

1.6 years

First QC Date

August 19, 2021

Last Update Submit

October 9, 2023

Conditions

Keywords

cancernutritionfood perceptions alterations

Outcome Measures

Primary Outcomes (1)

  • QVA questionnaire score difference between the 2 arms

    The main endpoint of CANUT-2 is the comparison of the overall score of the food quality of life questionnaire (Qualité de Vie Alimentaire QVA) between patients who received CANUT support and those who did not receive the CANUT support. The comparison is performed at the time of V2 i.e. after 4 cycles of chemotherapy treatment, corresponding with the end of study follow-up.

    At the end of study follow-up, up to 12 weeks

Secondary Outcomes (14)

  • QVA questionnaire score

    At the end of study follow-up, up to 12 weeks

  • QLQ-C30 score

    At the end of study follow-up, up to 12 weeks

  • Weight

    At the end of study follow-up, up to 12 weeks

  • waist size

    At the end of study follow-up, up to 12 weeks

  • hip size

    At the end of study follow-up, up to 12 weeks

  • +9 more secondary outcomes

Study Arms (2)

patients receiving CANUT support (guide + dietary interviews)

EXPERIMENTAL

Patients included in this arm will have following interventions : * CANUT support : patients will receive the CANUT guide (food guide) to help them deal with eating disorders encountered during their chemotherapy treatment ; the CANUT support includes calls from a dietician between chemotherapy cycles for support and advice. * anthropometric measures * Prehension strength measurement * food quality of life questionnaire (Qualité de Vie Alimentaire QVA) * Quality of Life Questionnaire Core 30 (QLQ C30) * Scratch \& Snif Test * Taste Strip Test * Nutrition interview * 24 H feed back questionnaire * condiment questionnaire * tobacco questionnaire

Other: CANUT supportOther: Anthropometric measuresOther: Prehension strength measurementBehavioral: QVA QuestionnaireBehavioral: QLQ C30 QuestionnaireBehavioral: Scratch & Snif TestBehavioral: Taste Strip TestBehavioral: 24 H feed back questionnaireBehavioral: Condiment questionnaireBehavioral: Tobacco questionnaireOther: Nutrition interview

patients not receiving canut support (guide + dietary interviews)

ACTIVE COMPARATOR

Patients included in this arm will have following interventions : * anthropometric measures * Prehension strength measurement * food quality of life questionnaire (Qualité de Vie Alimentaire QVA) * Quality of Life Questionnaire Core 30 (QLQ C30) * Scratch \& Snif Test * Taste Strip Test * Nutrition interview * 24 H feed back questionnaire * condiment questionnaire * tobacco questionnaire

Other: Anthropometric measuresOther: Prehension strength measurementBehavioral: QVA QuestionnaireBehavioral: QLQ C30 QuestionnaireBehavioral: Scratch & Snif TestBehavioral: Taste Strip TestBehavioral: 24 H feed back questionnaireBehavioral: Condiment questionnaireBehavioral: Tobacco questionnaireOther: Nutrition interview

Interventions

CANUT support includes delivery of the CANUT guide (food guide developed by Paul Bocuse Institute from previous results) ; it will be given to patient with explanations about the use of the guide. This also includes 2 calls from a dietician, performed between the 1st and the 3rd chemotherapy cycle to help patient personally with their food side effects.

patients receiving CANUT support (guide + dietary interviews)

These measures include weight, waist size, hip size and brachial circumference

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

Prehension strength will be assessed thanks to a hand grip device, that makes it possible to measure strength of all fingers, hands, wrists and forearms muscles

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

Food quality of life questionnaire

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

Quality of Life questionnaire Core 30

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

The Scratch \& Snif Test is used to assess olfactory capacities : patient has to scratch a box on a card, smell it and recognize the scent amongst a list of propositions

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

The Taste Strip Test is used to assess taste capacities : strips impregnated with different concentrations of the 5 basic taste qualities (sweet, sour, acid, bitter, umami) are successively placed on patient's tongue ; patient has to identify the taste bit by bit.

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

This questionnaire describes patient's food and drink intakes during the last 24 ours

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

This questionnaire used to assess condiments consumption

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

This questionnaire used to assess tobacco consumption

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

This interview will be conducted by a dietician

patients not receiving canut support (guide + dietary interviews)patients receiving CANUT support (guide + dietary interviews)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Major patient with one of the following 3 types of cancer:
  • histologically or cytologically proven localized breast cancer cytologically proven
  • Gynecological cancer (ovarian cancer or uterine cancer) stage III-IV without functional digestive signs related to the tumor disease
  • Patient with a body mass index (BMI) between 18 Kg/m² and 35 Kg/m².
  • Patient for whom the indication for treatment with a first line of intravenous chemotherapy (+/- targeted therapy) has been accepted by multidisciplinary meeting.
  • Patient naive to previous chemotherapy.
  • Life expectancy \> 3 months.
  • Patient with written informed consent
  • Patient affiliated to a French social security system.

You may not qualify if:

  • Patient under 18 years
  • Patient who had another malignancy within the last 3 years years, with the exception of carcinoma in situ of the cervix or cervical carcinoma in situ or adequately treated squamous cell carcinoma of the skin adequately treated, or basal cell skin cancer.This cancer must be adequately controlled.
  • Patients with symptomatic brain and/or meningeal metastases.
  • Patients with symptomatic mucositis.
  • Patients suffering or having suffered from an ear, nose and throat disease or oeso-gastro intestinal pathology interfering with the food intake.
  • Patients suffering from digestive disorders such as nausea prior to any cancer treatment.
  • Indication of concomitant radiotherapy or immunotherapy treatment alone.
  • Patients with a known food allergy or intolerance
  • Patient with diagnosed partial or total ageusia.
  • Patient with diagnosed partial or total anosmia.
  • Patient unable to be regularly followed for any reason (geographical, family, social, psychological,...).
  • Patient deprived of liberty or placed under guardianship or legal protection.
  • Pregnant or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Hôpital Louis Pradel, Service gynécologie

Bron, 69677, France

Location

Hôpital Louis Pradel, Service pneumologie

Bron, 69677, France

Location

Infirmerie Protestante

Caluire-et-Cuire, 69300, France

Location

Hôpital de la Croix Rousse, service pneumologie

Lyon, 69004, France

Location

Centre Léon Bérard, service gynécologie

Lyon, 69008, France

Location

Centre Léon Bérard, service pneumologie

Lyon, 69008, France

Location

Centre hospitalo-universitaire de Lyon Sud, service Oncologie médicale

Pierre-Bénite, 69310, France

Location

Centre hospitalo-universitaire de Lyon Sud, service pneumologie

Pierre-Bénite, 69310, France

Location

CHU St Etienne,

Saint-Etienne, 42270, France

Location

CH de Valence

Valence, 26 953, France

Location

MeSH Terms

Conditions

Breast NeoplasmsCarcinoma, BronchogenicNeoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2021

First Posted

August 30, 2021

Study Start

January 27, 2022

Primary Completion

September 21, 2023

Study Completion

September 21, 2023

Last Updated

October 11, 2023

Record last verified: 2023-10

Locations